Vaccine-preventable diseases and their impact on Latin American children

Expert Review of Vaccines

Volumn 10, Issue 12, 2011, Pages 1671-1673

  Ulloa Gutierrez, Rolando ^a   Miño, Greta ^b   Odio, Carla ^a   Avila Aguero, María L ^a   Brea, José ^c  

^a HOSPITAL NACIONAL DE NIÑOS   (Costa Rica)

^b Hospital del Niño Francisco de Icaza Bustamante   (Ecuador)

^c Pediatrics Medical School of the Centro Médico Universidad Central del Este   (Dominican Republic)

Author keywords

children; community acquired pneumonia; conference; Latin America; pediatric infectious diseases; vaccine preventable diseases; vaccines

Indexed keywords

CHICKENPOX VACCINE; DENGUE VACCINE; HAEMOPHILUS INFLUENZAE VACCINE; INFLUENZA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; ROTAVIRUS VACCINE;

BORDETELLA PERTUSSIS; CHILD; COMMUNITY ACQUIRED PNEUMONIA; CONFERENCE PAPER; DENGUE; HEALTH PROGRAM; HEPATITIS A VIRUS; HUMAN; INFLUENZA VIRUS; LIFE EXPECTANCY; MEDICAL SOCIETY; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PNEUMONIA; PRIORITY JOURNAL; ROTAVIRUS; SOUTH AND CENTRAL AMERICA; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VARICELLA ZOSTER VIRUS; WART VIRUS;

BACTERIAL VACCINES; CHILD; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; HUMANS; IMMUNIZATION PROGRAMS; LATIN AMERICA; VACCINATION; VIRAL VACCINES;

EID: 81355122721     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.11.153     Document Type: Conference Paper

References (17)

1. Debbag R. Dr. Hugó Rene Paganini (1959-2010). Rev. Chil. Infect. 28(Suppl. 1), S7-S8 (2011).
2. Vacchino MN. Incidence of hepatitis A in Argentina after vaccination. J. Viral Hepat. 15(Suppl. 2), S47-S50 (2008).
3. Centers for disease control and prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the advisory committee on immunization practices, 2010. MMWR Morb. Mortal. Wkly Rep. 60(1), 13-15 (2011).
4. Sáfadi MA, Cintra OA. Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention. Neurol. Res. 32(3), 263-271 (2010).
5. Chacón-Cruz E, Martínez-Longoria CA, Llausas-Magaña E et al. Red nacional para enfermedad meningocóccica y meningitis en México: resultados preliminares a un año de establecida la vigilancia activa en 10 hospitales. Presented at: XIV Congreso Latinoamericano de Infectología Pediátrica (SLIPE). Punta Cana, República, Dominicana, 25-28 May 2011 (Abstract Vac-12).
6. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N. Engl. J. Med. 362(4), 299-305 (2010).
7. Sáfadi MA, Berezin EN, Munford V et al. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil. Pediatr. Infect. Dis. J. 29(11), 1019-1022 (2010).
8. Yen C, Armero Guardado JA, Alberto P et al. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador. Pediatr. Infect. Dis. J. 30(Suppl. 1), S6-S10 (2011).
9. Molto Y, Cortes JE, De Oliveira LH et al. Reduction of diarrhea-associated hospitalizations among children aged <5 years in Panama following the introduction of rotavirus vaccine Pediatr. Infect. Dis. J. 30 1 S16-S20 2011
10. Quian J, Rüttimann R, Romero C et al. Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997-2005. Arch. Dis. Child. 93(10), 845-850 (2008).
11. Shieh WJ, Blau DM, Denison AM et al. 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am. J. Pathol. 177(1), 166-175 (2010).
12. Simonsen L, Taylor RJ, Young-Xu Y, Haber M, May L, Klugman KP. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio 2(1), e00309-e00310 (2011).
13. Pírez MC, Algorta G, Cedrés A et al. Impact of universal pneumococcal vaccination on hospitalizations for pneumonia and meningitis in children in Montevideo, Uruguay. Pediatr. Infect. Dis. J. 30(8), 669-674 (2011).
14. Tregnaghi MW, Sáez-Llorens X, López P et al. Evaluating the efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine (PHiD-CV) against community-acquired pneumonia in Latin America. Presented at: 29th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID). The Hague, The Netherlands, 7-11 June 2011 (Abstract 1411).
15. Salas-Peraza D, Avila-Agüero ML, Morice-Trejos A. Switching from OPV to IPV: are we behind the schedule in Latin America? Expert Rev. Vaccines 9(5), 475-483 (2010).
16. San Martín JL, Brathwaite O, Zambrano B et al. The epidemiology of dengue in the Americas over the last three decades: a worrisome reality. Am. J. Trop. Med. Hyg. 82(1), 128-135 (2010).
17. Shepard DS, Coudeville L, Halasa YA, Zambrano B, Dayan GH. Economic impact of dengue illness in the Americas. Am. J. Trop. Med. Hyg. 84(2), 200-207 (2011).